Board of Directors

Executive Committee:

  • David Main, President & CEO, Aquinox Pharmaceuticals (Chairman)
  • Paul Petrelli, President & General Manager, Canada, Biogen Canada Inc. (Vice Chair)
  • Kevin Leshuk, General Manager, Celgene Inc. (Treasurer)
  • Andrew Casey, President & CEO, BIOTECanada (Secretary)
  • Brad Thompson, President & CEO, Oncolytics Biotech Inc. (past-Chair)

Directors:

  • Roberto Bellini, President & CEO, Bellus Health
  • Brian Bloom, President, Bloom Burton & Co.
  • Neal Carter, President & Founder, Okanagan Specialty Fruits
  • Natalie Dakers, CEO, Accel-Rx Health Sciences
  • Michel Fortin, President & CEO, Prevtec Microbia Inc.
  • Diane Gosselin, President & CEO, CQDM
  • John Haslam, General Manager, Alexion Pharmaceuticals
  • Brian Hilberdink, President, Novo Nordisk Canada Inc.
  • Mark Lievonen, President, Sanofi Pasteur Limited
  • A.J. (Sandy) Marshall, Chairman, Bioindustrial Innovation Canada
  • Gordon McCauley, Partner, Viable Healthworks Corporation
  • John Norman, Partner, Gowling Lafleur Henderson LLP
  • Greg Penner, President & CEO, NeoVentures Biotechnology Inc.
  • Sanj Singh, President & CEO, Ade Therapeutics
  • Shermaine Tilley, Managing Partner, CTI Life Sciences Fund
  • Oliver Technow, CEO, BioVectra Inc.
  • Eric Tse, General Manager, Shire Pharma Canada ULC
  • Dan Wattier, CEO, ImStar Therapeutics